Literature DB >> 7586735

A CD3+CD8+ T cell population lacking CD5 antigen expression is expanded in peripheral blood of human immunodeficiency virus-infected patients.

S Indraccolo1, M Mion, R Zamarchi, V Coppola, F Calderazzo, A Amadori, L Chieco-Bianchi.   

Abstract

In this study we analyzed the behavior of a CD3+ T cell subpopulation lacking CD5 antigen expression in PBMC from HIV-1-infected patients. CD3+CD5- lymphocytes were greatly increased in peripheral blood of HIV-1+ patients, accounting for 20.6 +/- 9.9% of the total CD3+ cells, compared to seronegative individuals (5.5 +/- 3.2%). In both seropositive patients and controls, CD3+CD5- cells belonged to the CD8+ compartment; they were nonactivated, TCR alpha/beta+, naive lymphocytes, and in seronegative individuals preferentially expressed NK cell-associated markers, such as CD11b, CD16, CD56, and CD57. The phenotypic profile of this subset was slightly different in seropositive patients; while TCR expression and CD45RA/RO profile were comparable, CD11b and CD16 expression was lower compared to control figures, while CD56 expression was not changed, and CD57 expression was enhanced. Functional analysis of enriched CD3+CD8+CD5- cells showed an impaired ability to proliferate in response to mitogenic and antigenic stimuli; despite their NK-like phenotype, CD3+CD8+CD5- cells did not exert any NK cytotoxic activity, and only a lectin-dependent cytotoxic potential could be evidenced in this population. These results describe a novel alteration in the lymphocytes phenotypic profile during HIV-1 infection, involving a "transitional" population, which shares some properties of the T and of the NK cell lineage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586735     DOI: 10.1006/clin.1995.1151

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  4 in total

1.  Genetic variability of the human CD4 V2 domain.

Authors:  S Indraccolo; M Mion; R Biagiotti; S Romagnani; M Morfini; G Longo; R Zamarchi; L Chieco-Bianchi; A Amadori
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity.

Authors:  Adrienne Verhoef; Clare Alexander; A Barry Kay; Mark Larché
Journal:  PLoS Med       Date:  2005-03-29       Impact factor: 11.069

3.  Greater frequency of CD5-negative CD8(+) T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation.

Authors:  Stephen J Penney; Maureen E Gallant; Michael D Grant
Journal:  AIDS Res Ther       Date:  2014-09-15       Impact factor: 2.250

4.  T-cell modulatory properties of CD5 and its role in antitumor immune responses.

Authors:  Mouna Tabbekh; M'barka Mokrani-Hammani; Georges Bismuth; Fathia Mami-Chouaib
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.